Published in Prog Cardiovasc Dis on August 23, 2010
Drug-induced oxidative stress and toxicity. J Toxicol (2012) 1.55
Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal (2011) 1.34
Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol (2011) 1.12
Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis (2013) 1.08
Mechanisms and management of doxorubicin cardiotoxicity. Herz (2011) 1.05
Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy. PLoS One (2012) 0.99
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Br J Cancer (2011) 0.96
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress. Oxid Med Cell Longev (2015) 0.95
Iron chelators with topoisomerase-inhibitory activity and their anticancer applications. Antioxid Redox Signal (2012) 0.91
Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer. J Breast Cancer (2016) 0.91
Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int (2012) 0.86
Rodent models of heart failure: an updated review. Heart Fail Rev (2013) 0.85
Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment. Front Oncol (2014) 0.85
A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor. Front Genet (2013) 0.84
Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. PLoS One (2013) 0.83
ROCK1 deficiency enhances protective effects of antioxidants against apoptosis and cell detachment. PLoS One (2014) 0.82
Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation. Am J Physiol Heart Circ Physiol (2012) 0.82
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs. Biomed Res Int (2015) 0.81
Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeutics. Int J Mol Sci (2012) 0.81
Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention. Clujul Med (2014) 0.80
Early cardiac function monitoring for detection of subclinical Doxorubicin cardiotoxicity in young adult patients with breast cancer. J Breast Cancer (2013) 0.80
Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. Cardiovasc Res (2016) 0.80
Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors. J Oncol (2015) 0.78
Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up. PLoS One (2014) 0.78
Dissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1. PLoS One (2015) 0.78
Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice. Cell Stress Chaperones (2014) 0.77
Apoptosis in Anthracycline Cardiomyopathy. Curr Pediatr Rev (2011) 0.77
Disordering of human telomeric G-quadruplex with novel antiproliferative anthrathiophenedione. PLoS One (2011) 0.77
Adult Acute Myeloid Leukemia Long-term Survivors. J Leuk (Los Angel) (2014) 0.76
The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer. PLoS One (2015) 0.76
Anthracycline treatment and ventricular remodeling in left ventricular assist device patients. Tex Heart Inst J (2015) 0.76
PET Metabolic Biomarkers for Cancer. Biomark Cancer (2016) 0.75
An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice. PLoS One (2017) 0.75
Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes. Medicine (Baltimore) (2016) 0.75
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Intra-patient Variability of FDG Standardized Uptake Values in Mediastinal Blood Pool, Liver, and Myocardium during R-CHOP Chemotherapy in Patients with Diffuse Large B-cell Lymphoma. Nucl Med Mol Imaging (2016) 0.75
How do we fit ferroptosis in the family of regulated cell death? Cell Death Differ (2017) 0.75
Cardiac spheroids as promising in vitro models to study the human heart microenvironment. Sci Rep (2017) 0.75
Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. J Am Heart Assoc (2017) 0.75
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med (2001) 44.67
Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (1995) 17.76
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev (2004) 9.28
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol (1999) 5.67
Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer (2003) 4.89
The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc (2008) 4.00
Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation (2001) 3.98
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med (2004) 3.50
ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med (2002) 3.36
Home-based physical activity intervention for breast cancer patients. J Clin Oncol (2005) 3.14
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res (2000) 2.84
Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol (2005) 2.72
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin Oncol (1999) 2.66
Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem (1998) 2.42
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J (1990) 2.41
Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation (1997) 2.34
Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res (2000) 2.33
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc Natl Acad Sci U S A (2002) 2.32
Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol (2010) 2.18
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci U S A (2004) 2.07
The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest (1996) 2.07
Physical Activity Guidelines Advisory Committee report, 2008. To the Secretary of Health and Human Services. Part A: executive summary. Nutr Rev (2009) 1.99
The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest (2007) 1.98
Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. J Cell Biol (2001) 1.97
Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Mol Cell Biol (1999) 1.95
Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology (2005) 1.89
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
GATA transcription factors and cardiac development. Semin Cell Dev Biol (1999) 1.81
Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol (2003) 1.80
Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity. Circulation (2002) 1.77
Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol (1997) 1.75
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res (2002) 1.72
Titin develops restoring force in rat cardiac myocytes. Circ Res (1996) 1.67
Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature (1995) 1.62
Early and delayed clinical cardiotoxicity of doxorubicin. Cancer (1985) 1.61
Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes. J Biol Chem (2003) 1.60
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A (1990) 1.59
Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children. J Clin Oncol (1996) 1.57
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci U S A (2000) 1.55
A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem (1997) 1.54
Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol (2003) 1.45
Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol (2009) 1.39
Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog Horm Res (2004) 1.39
Studies on cardiac myofibrillogenesis with antibodies to titin, actin, tropomyosin, and myosin. J Cell Biol (1988) 1.38
Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res (1999) 1.31
Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription. Mol Cell Biol (2000) 1.31
Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med (2004) 1.23
Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res (1988) 1.20
The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine. Mol Interv (2005) 1.20
Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med (1997) 1.20
Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol (2005) 1.18
The type I growth factor receptors in human breast cancer. Breast Cancer Res Treat (1994) 1.17
Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity. Circulation (2000) 1.13
Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci (2001) 1.12
Titin determines the Frank-Starling relation in early diastole. J Gen Physiol (2003) 1.10
Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J (1986) 1.08
Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle. Am J Physiol Cell Physiol (2003) 1.08
The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer. J Biol Response Mod (1990) 1.07
Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett (2004) 1.06
The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review. J Cancer Res Clin Oncol (2003) 1.03
Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res (1997) 1.03
Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci (2004) 1.03
The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J (2004) 1.02
Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J Gene Med (2003) 1.00
Assessment of anthracycline cardiomyopathy by endomyocardial biopsy. Ultrastruct Pathol (1994) 0.99
Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of PI 3 kinase/Akt pathway. Mol Cell Endocrinol (2003) 0.97
Exercise as a coronary protective factor. Am Heart J (1991) 0.97
ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity. J Mol Med (Berl) (2009) 0.97
Relation of exercise to the recurrence rate of myocardial infarction in men. Ontario Exercise-Heart Collaborative Study. Am J Cardiol (1983) 0.96
Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp Clin Cardiol (2003) 0.94
Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events. J Mol Biol (1992) 0.92
Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy. Drugs (1998) 0.91
Thermal preconditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis. Life Sci (1999) 0.91
Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. J Appl Physiol (1985) (1985) 0.91
Autophagy in the myocardium: Dying for survival? Exp Clin Cardiol (2006) 0.89
The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training. Eur J Appl Physiol (2005) 0.88
Intervention of adriamycin induced free radical damage. Biochem Int (1992) 0.88
Peroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase. Biochimie (2002) 0.86
Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity. Mol Pharmacol (2002) 0.85
Interaction and inhibitory cross-talk between endothelin and ErbB receptors in the adult heart. Mol Pharmacol (2007) 0.84
TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity. J Cardiovasc Pharmacol (2008) 0.83
Effects of in vitro and in vivo exposure to doxorubicin (adriamycin) on caffeine-induced Ca2+ release from sarcoplasmic reticulum and contractile protein function in 'chemically-skinned' rabbit ventricular trabeculae. Jpn J Pharmacol (1998) 0.82
Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention. Br J Pharmacol (1996) 0.82
Regulation of myocardial heat shock protein 70 gene expression following exercise. J Mol Cell Cardiol (2004) 0.82
Assessment of PI-3 kinase and Akt in ischemic heart diseases in diabetes. Methods Mol Med (2007) 0.81
Ultrastructural morphometric analysis of endomyocardial biopsies. Idiopathic dilated cardiomyopathy, anthracycline cardiotoxicity, and normal myocardium. Am J Cardiovasc Pathol (1988) 0.80
The effect of first-dose doxorubicin on the cyclic nucleotide levels of the human myocardium. Toxicol Appl Pharmacol (1981) 0.79
Properties of G-protein modulated receptor-adenylyl cyclase system in myocardium of spontaneously hypertensive rats treated with adriamycin. Int J Cardiol (1994) 0.77
Adriamycin-induced changes to the myocardial beta-adrenergic system in the rabbit. J Mol Cell Cardiol (1991) 0.77
Clinical decision making vs programme evaluation perspectives. Pharmacoeconomics (1993) 0.76
Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging (2012) 2.86
Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res (2003) 1.99
Circulating vascular growth factors and central hemodynamic load in the community. Hypertension (2012) 1.56
Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. J Mol Cell Cardiol (2006) 1.33
Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation (2002) 1.24
The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine. Mol Interv (2005) 1.20
Molecular and cellular mechanisms of anthracycline cardiotoxicity. Cardiovasc Toxicol (2007) 1.17
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation (2009) 1.12
Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol (2010) 1.11
Titin determines the Frank-Starling relation in early diastole. J Gen Physiol (2003) 1.10
Optogenetic inhibition of dorsal medial prefrontal cortex attenuates stress-induced reinstatement of palatable food seeking in female rats. J Neurosci (2013) 1.09
A novel microfluidic impedance assay for monitoring endothelin-induced cardiomyocyte hypertrophy. Biosens Bioelectron (2006) 0.99
The continuing evolution of the Langendorff and ejecting murine heart: new advances in cardiac phenotyping. Am J Physiol Heart Circ Physiol (2012) 0.99
Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy. PLoS One (2012) 0.99
Simultaneous orientation and cellular force measurements in adult cardiac myocytes using three-dimensional polymeric microstructures. Cell Motil Cytoskeleton (2007) 0.94
Myocyte contractile activity modulates norepinephrine cytotoxicity and survival effects of neuregulin-1beta. Am J Physiol Cell Physiol (2003) 0.90
Palmitate alters neuregulin signaling and biology in cardiac myocytes. Biochem Biophys Res Commun (2008) 0.86
Cardiac side effects of anticancer treatments: new mechanistic insights. Curr Heart Fail Rep (2012) 0.86
Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction. PLoS One (2013) 0.86
Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development. Development (2013) 0.84
Neuregulin-1β regulation of embryonic endothelial progenitor cell survival. Am J Physiol Heart Circ Physiol (2011) 0.83
A curious case of Lactobacillus casei in a prosthetic joint: was it the yogurt? J Am Geriatr Soc (2012) 0.83
ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response. Biochem Biophys Res Commun (2012) 0.82
Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes. Exp Physiol (2006) 0.81
26S proteasome regulation of Ankrd1/CARP in adult rat ventricular myocytes and human microvascular endothelial cells. Biochem Biophys Res Commun (2012) 0.80
Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern? Circ Res (2010) 0.79
Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein. Am J Physiol Heart Circ Physiol (2008) 0.79
Optical splitting trees for high-precision monocular imaging. IEEE Comput Graph Appl (2007) 0.75
Distribution and sources of phthalate esters in the topsoils of Beijing, China. Environ Geochem Health (2013) 0.75